Search Within

Ann Elizabeth Sisk

Formats
  1. Journal Article (4)
  2. Meeting Abstract (1)
Groups
  1. Department of Medicine (5)
  2. Solid Tumor Oncology Division (5)
  3. Thoracic Oncology (4)
  4. CTCR Scholars (3)
  5. Department of Pathology and Laboratory Medicine (3)
  6. Hematology-Oncology Fellows (3)

More Groups

People
  1. Alexander Drilon (3)
  2. Yonina Murciano-Goroff (3)
  3. Erica Sgroe (2)
  4. James Harding (2)
  5. Jamie Gibson (2)
  6. Jason Chang (2)

More People

Years
  1. 2025 (1)
  2. 2022 (2)
  3. 2021 (2)
Publications
  1. Cancer Medicine (1)
  2. Cancer Research (1)
  3. Clinical Cancer Research (1)
  4. Clinical and Translational Medicine (1)
  5. Nature (1)
Publishers
  1. American Association for Cancer Research (2)
  2. John Wiley & Sons (1)
  3. Nature Publishing Group (1)
  4. Wiley Blackwell (1)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Responsiveness of different MET tumour alterations to type I and type II MET inhibitors
    Journal Article

    Murciano-Goroff, Y. R.; Foglizzo, V.; Chang, J.; Rekhtman, N.; Sisk, A. E.; Gibson, J.; Judka, L.; Clemens, K.; Roa, P.; Ahmed, S. S.; more...
    Clinical and Translational Medicine (2025)

    Fulltext@MSK | Save
  • Switching inhibitor class overcomes crizotinib resistance in a MET fusion-positive NSCLC with a novel acquired MET G1090A mutation
    Meeting Abstract

    Murciano-Goroff, Y. R.; Kannan, S.; Chang, J. C.; Benayed, R.; Blokhin, I.; Rekhtman, N.; Sisk, A. E.; Gibson, J.; Judka, L.; Kaplanis, L.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment
    Journal Article

    Liu, D.; Weintraub, M. A.; Garcia, C.; Goncalves, M. D.; Sisk, A. E.; Casas, A.; Harding, J. J.; Harnicar, S.; Drilon, A.; Jhaveri, K.; more...
    Cancer Medicine (2022)

    Fulltext@MSK | Save
  • Diverse alterations associated with resistance to KRAS(G12C) inhibition
    Journal Article

    Zhao, Y.; Murciano-Goroff, Y. R.; Xue, J. Y.; Ang, A.; Lucas, J.; Mai, T. T.; Da Cruz Paula, A. F.; Saiki, A. Y.; Mohn, D.; Achanta, P.; more...
    Nature (2021)

    Fulltext@MSK | Save
  • Phase II clinical trial of everolimus in a pan-cancer cohort of patients with mTOR pathway alterations
    Journal Article

    Adib, E.; Klonowska, K.; Giannikou, K.; Do, K. T.; Pruitt-Thompson, S.; Bhushan, K.; Milstein, M. I.; Hedglin, J.; Kargus, K. E.; Sholl, L. M.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save